Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice

► We have developed an influenza vaccine with cross protective immunity. ► The vaccine fully protects against seasonal and pandemic H1N1 influenza viruses in mice. ► Vaccine also fully protects against H5N1 influenza virus. ► Vaccine has the potential to protect against small pox virus.